A clinical case definition of post-COVID-19 condition by a Delphi consensus
- PMID: 34951953
- PMCID: PMC8691845
- DOI: 10.1016/S1473-3099(21)00703-9
A clinical case definition of post-COVID-19 condition by a Delphi consensus
Abstract
People with COVID-19 might have sustained postinfection sequelae. Known by a variety of names, including long COVID or long-haul COVID, and listed in the ICD-10 classification as post-COVID-19 condition since September, 2020, this occurrence is variable in its expression and its impact. The absence of a globally standardised and agreed-upon definition hampers progress in characterisation of its epidemiology and the development of candidate treatments. In a WHO-led Delphi process, we engaged with an international panel of 265 patients, clinicians, researchers, and WHO staff to develop a consensus definition for this condition. 14 domains and 45 items were evaluated in two rounds of the Delphi process to create a final consensus definition for adults: post-COVID-19 condition occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from the onset, with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis. Common symptoms include, but are not limited to, fatigue, shortness of breath, and cognitive dysfunction, and generally have an impact on everyday functioning. Symptoms might be new onset following initial recovery from an acute COVID-19 episode or persist from the initial illness. Symptoms might also fluctuate or relapse over time. A separate definition might be applicable for children. Although the consensus definition is likely to change as knowledge increases, this common framework provides a foundation for ongoing and future studies of epidemiology, risk factors, clinical characteristics, and therapy.
Copyright © 2022 World Health Organization. Published by Elsevier Ltd.All rights reserved. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests We declare no competing interests.
Figures
Comment in
-
Defining post-COVID condition.Lancet Infect Dis. 2022 Mar;22(3):316-317. doi: 10.1016/S1473-3099(22)00060-3. Lancet Infect Dis. 2022. PMID: 35218747 Free PMC article. No abstract available.
-
Prevalence of post-COVID-19 condition in the French general population after the first epidemic waves.Infect Dis Now. 2023 Feb;53(1):104631. doi: 10.1016/j.idnow.2022.10.003. Epub 2022 Nov 8. Infect Dis Now. 2023. PMID: 36368627 Free PMC article. No abstract available.
Similar articles
-
Long COVID (post-COVID-19 condition) in children: a modified Delphi process.Arch Dis Child. 2022 Jul;107(7):674-680. doi: 10.1136/archdischild-2021-323624. Epub 2022 Apr 1. Arch Dis Child. 2022. PMID: 35365499 Free PMC article.
-
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study.Lancet Respir Med. 2022 Jul;10(7):715-724. doi: 10.1016/S2213-2600(22)00169-2. Epub 2022 Jun 14. Lancet Respir Med. 2022. PMID: 35714658 Free PMC article. Review.
-
Long-Term COVID 19 Sequelae in Adolescents: the Overlap with Orthostatic Intolerance and ME/CFS.Curr Pediatr Rep. 2022;10(2):31-44. doi: 10.1007/s40124-022-00261-4. Epub 2022 Mar 9. Curr Pediatr Rep. 2022. PMID: 35287333 Free PMC article. Review.
-
Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.Rev Neurol. 2021 Jun 1;72(11):384-396. doi: 10.33588/rn.7211.2021230. Rev Neurol. 2021. PMID: 34042167 Review. English, Spanish.
-
Italian intersociety consensus on management of long covid in children.Ital J Pediatr. 2022 Mar 9;48(1):42. doi: 10.1186/s13052-022-01233-6. Ital J Pediatr. 2022. PMID: 35264214 Free PMC article. Review.
Cited by
-
Clinical and endocrine features of orthostatic intolerance detected in patients with long COVID.Sci Rep. 2024 Jul 24;14(1):17025. doi: 10.1038/s41598-024-67815-y. Sci Rep. 2024. PMID: 39043760
-
Autoantibodies in COVID-19 survivors with post-COVID symptoms: a systematic review.Front Immunol. 2024 Jul 5;15:1428645. doi: 10.3389/fimmu.2024.1428645. eCollection 2024. Front Immunol. 2024. PMID: 39035011 Free PMC article.
-
Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review.Am J Med Open. 2024 Feb 14;11:100068. doi: 10.1016/j.ajmo.2024.100068. eCollection 2024 Jun. Am J Med Open. 2024. PMID: 39034937 Free PMC article.
-
Tracking cognitive trajectories in older survivors of COVID-19 up to 2.5 years post-infection.Nat Aging. 2024 Jul 10. doi: 10.1038/s43587-024-00667-3. Online ahead of print. Nat Aging. 2024. PMID: 38987646
-
COVID-19 and long-term impact on symptoms and Health-Related Quality of Life in Costa Rica: the RESPIRA cohort study.BMC Infect Dis. 2024 Jun 4;24(1):557. doi: 10.1186/s12879-024-09450-6. BMC Infect Dis. 2024. PMID: 38834971 Free PMC article.
References
-
- WHO World health statistics. 2021. https://www.who.int/data/gho/publications/world-health-statistics
-
- The Royal Society Long Covid: what is it, and what is needed? Oct 23, 2020. https://royalsociety.org/-/media/policy/projects/set-c/set-c-long-covid.pdf
-
- Thompson EJ, Williams DM, Walker AJ, et al. Risk factors for long COVID: analyses of 10 longitudinal studies and electronic health records in the UK. medRxiv. 2021 doi: 10.1101/2021.06.24.21259277. published online Jan 1. (preprint). - DOI
-
- Whitaker M, Elliott J, Chadeau-Hyam M, et al. Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people. medRxiv. 2021 doi: 10.1101/2021.06.28.21259452. published online Jan 1. (preprint). - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous